CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

$3.31
-0.81 (-19.66%)
As of Sep 28, 10:32 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,069.8% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $3.31
Current
$3.31
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
660.4%
Low target
Base Case
$38.72
+1,069.8%
Avg target
Bull Case
$55.57
+1,578.9%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$4.14
-20.0% from high
52-Week Low
$0.29
+1,041.4% from low
Target vs 52W High
$38.72
+835.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%